136 related articles for article (PubMed ID: 35724847)
1. Hepatic bile acid synthesis and secretion: Comparison of in vitro methods.
de Bruijn VMP; Wang Z; Bakker W; Zheng W; Spee B; Bouwmeester H
Toxicol Lett; 2022 Jul; 365():46-60. PubMed ID: 35724847
[TBL] [Abstract][Full Text] [Related]
2. Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.
Qiu X; Zhang Y; Liu T; Shen H; Xiao Y; Bourner MJ; Pratt JR; Thompson DC; Marathe P; Humphreys WG; Lai Y
Mol Pharm; 2016 Apr; 13(4):1206-16. PubMed ID: 26910619
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte-based in vitro model for assessment of drug-induced cholestasis.
Chatterjee S; Richert L; Augustijns P; Annaert P
Toxicol Appl Pharmacol; 2014 Jan; 274(1):124-36. PubMed ID: 24211272
[TBL] [Abstract][Full Text] [Related]
4. Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes.
Susukida T; Sekine S; Ogimura E; Aoki S; Oizumi K; Horie T; Ito K
Toxicol In Vitro; 2015 Oct; 29(7):1454-63. PubMed ID: 26055650
[TBL] [Abstract][Full Text] [Related]
5. Metabolic preconditioning protects BSEP/ABCB11
Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
[TBL] [Abstract][Full Text] [Related]
6. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
[TBL] [Abstract][Full Text] [Related]
7. Predictive Value of Cellular Accumulation of Hydrophobic Bile Acids As a Marker of Cholestatic Drug Potential.
Burban A; Sharanek A; Humbert L; Eguether T; Guguen-Guillouzo C; Rainteau D; Guillouzo A
Toxicol Sci; 2019 Apr; 168(2):474-485. PubMed ID: 30629237
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a Drug-Induced, Bile Acid-Dependent Hepatotoxicity Model Using HepaRG Cells.
Susukida T; Sekine S; Nozaki M; Tokizono M; Oizumi K; Horie T; Ito K
J Pharm Sci; 2016 Apr; 105(4):1550-60. PubMed ID: 26952880
[TBL] [Abstract][Full Text] [Related]
9. Role of the bile salt export pump, BSEP, in acquired forms of cholestasis.
Stieger B
Drug Metab Rev; 2010 Aug; 42(3):437-45. PubMed ID: 20028269
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic model to generate mechanistic insights in bile acid homeostasis and drug-induced cholestasis.
de Bruijn VMP; Rietjens IMCM; Bouwmeester H
Arch Toxicol; 2022 Oct; 96(10):2717-2730. PubMed ID: 35876888
[TBL] [Abstract][Full Text] [Related]
11. Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes.
Petrov PD; Fernández-Murga L; Conde I; Martínez-Sena T; Guzmán C; Castell JV; Jover R
Arch Toxicol; 2020 Feb; 94(2):589-607. PubMed ID: 31894354
[TBL] [Abstract][Full Text] [Related]
12. Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates.
Chatterjee S; Bijsmans IT; van Mil SW; Augustijns P; Annaert P
Toxicol In Vitro; 2014 Mar; 28(2):218-30. PubMed ID: 24211540
[TBL] [Abstract][Full Text] [Related]
13. Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression.
Garzel B; Hu T; Li L; Lu Y; Heyward S; Polli J; Zhang L; Huang SM; Raufman JP; Wang H
Pharm Res; 2020 Jan; 37(2):26. PubMed ID: 31907698
[TBL] [Abstract][Full Text] [Related]
14. Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes.
Sharanek A; Burban A; Humbert L; Bachour-El Azzi P; Felix-Gomes N; Rainteau D; Guillouzo A
Toxicol Sci; 2015 Oct; 147(2):573-87. PubMed ID: 26198044
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine 1-phosphate receptor-1 specific agonist SEW2871 ameliorates ANIT-induced dysregulation of bile acid homeostasis in mice plasma and liver.
Yang T; Wang X; Yuan Z; Miao Y; Wu Z; Chai Y; Yu Q; Wang H; Sun L; Huang X; Zhang L; Jiang Z
Toxicol Lett; 2020 Oct; 331():242-253. PubMed ID: 32579994
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump.
Rodrigues AD; Lai Y; Cvijic ME; Elkin LL; Zvyaga T; Soars MG
Drug Metab Dispos; 2014 Apr; 42(4):566-74. PubMed ID: 24115749
[TBL] [Abstract][Full Text] [Related]
17. Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes.
Kruglov EA; Gautam S; Guerra MT; Nathanson MH
Hepatology; 2011 Nov; 54(5):1790-9. PubMed ID: 21748767
[TBL] [Abstract][Full Text] [Related]
18. Metformin impairs bile acid homeostasis in ethinylestradiol-induced cholestasis in mice.
Faradonbeh FA; Sa II; Lastuvkova H; Cermanova J; Hroch M; Faistova H; Mokry J; Nova Z; Uher M; Nachtigal P; Pavek P; Micuda S
Chem Biol Interact; 2021 Aug; 345():109525. PubMed ID: 34058177
[TBL] [Abstract][Full Text] [Related]
19. BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.
Kis E; Ioja E; Rajnai Z; Jani M; Méhn D; Herédi-Szabó K; Krajcsi P
Toxicol In Vitro; 2012 Dec; 26(8):1294-9. PubMed ID: 22120137
[TBL] [Abstract][Full Text] [Related]
20. Oleanolic acid alters bile acid metabolism and produces cholestatic liver injury in mice.
Liu J; Lu YF; Zhang Y; Wu KC; Fan F; Klaassen CD
Toxicol Appl Pharmacol; 2013 Nov; 272(3):816-24. PubMed ID: 23948738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
